Pine Valley Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330K Buy
2,610
+183
+8% +$24.1K 0.01% 479
2026
Q1
$338K Buy
2,427
+262
+12% +$36.7K 0.02% 445
2025
Q4
$266K Sell
2,165
-226
-9% -$27.5K 0.01% 473
2025
Q3
$265K Hold
2,391
0.01% 465
2025
Q2
$265K Buy
2,391
+20
+0.8% +$2.13K 0.01% 452
2025
Q1
$266K Sell
2,371
-130
-5% -$13.4K 0.02% 441
2024
Q4
$231K Buy
2,501
+6
+0.2% +$540 0.01% 464
2024
Q3
$209K Buy
+2,495
New +$190K 0.01% 476
2024
Q2
Sell
-3,080
Closed -$226K 501
2024
Q1
$226K Sell
3,080
-211
-6% -$16.2K 0.02% 452
2023
Q4
$267K Buy
+3,291
New +$256K 0.02% 406

Other funds holding GILD

Pine Valley Investments's GILD Position: Q2 2026 in Review

Pine Valley Investments increased its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, buying an estimated $24.1K and bringing the position to 2,610 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #479.

Pine Valley Investments first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $338K in Q1 2026. 1,239 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pine Valley Investments held 2,610 shares of Gilead Sciences worth $330K as of Q2 2026.
  • Pine Valley Investments bought 183 Gilead Sciences shares in Q2 2026, an estimated $24.1K.
  • Gilead Sciences made up 0.01% of Pine Valley Investments's portfolio in Q2 2026, its #479 holding.
  • Pine Valley Investments first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Pine Valley Investments's Gilead Sciences position peaked at $338K in Q1 2026.
  • 1,239 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.